Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) 5-Year EBITDA Growth Rate : 18.90% (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co 5-Year EBITDA Growth Rate?

Jiangsu Lianhuan Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.18.

During the past 12 months, Jiangsu Lianhuan Pharmaceutical Co's average EBITDA Per Share Growth Rate was -3.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 18.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Jiangsu Lianhuan Pharmaceutical Co was 33.40% per year. The lowest was -10.40% per year. And the median was 17.85% per year.

Competitive Comparison of Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.

Jiangsu Lianhuan Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Jiangsu Lianhuan Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009

Website

http://www.lhpharma.com

Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.

Executives

Chu Qing Song	senior management
Xia Chun Lai	Director
Pan He Ping	Directors, senior managers
Niu Ben	senior management
Wu Wen Ge	Director
Zhu Yong Jun	senior management
Qian Zhen Hua	Director
Shen Yi	senior management
Huang Wen Tao	senior management
Zhou Jun	senior management
Tu Bin	senior management
Qin Xiong Jian	senior management

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines